Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Octopus BiosafetyFRA:OCR +23.15%7 Equity-to-Asset is -1.34 as of Dec. 2024. GuruFocus rates FRA:OCR with a GF Score™ of 7/100. The stock has 2 warning signs investors should review. Among 2,494 Hardware companies, Octopus Biosafety ranks worse than 98.72% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Octopus Biosafety's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €-0.66 Mil. Octopus Biosafety's Total Assets for the quarter that ended in Dec. 2024 was €0.49 Mil.
Therefore, Octopus Biosafety's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was -1.34.
The historical rank and industry rank for Octopus Biosafety's Equity-to-Asset or its related term are showing as below:
FRA:OCR'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.34 Med: 0 Max: 0.6
Current: -1.34
During the past 10 years, the highest Equity to Asset Ratio of Octopus Biosafety was 0.60. The lowest was -1.34. And the median was 0.00.
FRA:OCR's Equity-to-Asset is ranked worse than 98.72% of 2494
companies
in the Hardware industry
Industry Median: 0.56
vs FRA:OCR: -1.34
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Octopus Biosafety Equity-to-Asset Related Terms
Octopus Biosafety Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:OCR vs DELL, ANET, SNDK: Equity-to-Asset Comparison
For the Computer Hardware subindustry, Octopus Biosafety's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety Equity-to-Asset vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Octopus Biosafety's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety (FRA:OCR) has a Equity-to-Asset of -1.34 as of Dec. 2024. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Octopus Biosafety and its competitors. According to the industry distribution chart, Octopus Biosafety ranks #2462 out of 2494 companies in the Hardware industry, placing it in the top 98.7%.
Is Octopus Biosafety's Equity-to-Asset too high?
Octopus Biosafety's current Equity-to-Asset is -1.34. Based on the distribution chart, Octopus Biosafety ranks #2462 out of 2494 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Octopus Biosafety has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Equity-to-Asset compare to DELL and ANET?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #2462 out of 2494 companies for Equity-to-Asset. This places Octopus Biosafety in the lower half of its industry. The industry median Equity-to-Asset is 0.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Hardware company?
The median Equity-to-Asset among Hardware companies is 0.56, based on 2,494 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median Equity-to-Asset is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current Equity-to-Asset is -1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (FRA:OCR) has a current Equity-to-Asset of -1.34. The current Equity-to-Asset is -1.34. Octopus Biosafety's overall GF Score™ is 7/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Octopus Biosafety (FRA:OCR), the current Equity-to-Asset is -1.34 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
7GF Score
Get the complete analysis for FRA:OCR
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OCR has been successfully added to your 
